169 related articles for article (PubMed ID: 16689335)
1. [Estrogens and leiomyoma of the uterus].
Murakami T
Nihon Rinsho; 2006 Apr; 64 Suppl 4():364-9. PubMed ID: 16689335
[No Abstract] [Full Text] [Related]
2. Hormones and pathogenesis of uterine fibroids.
Reis FM; Bloise E; Ortiga-Carvalho TM
Best Pract Res Clin Obstet Gynaecol; 2016 Jul; 34():13-24. PubMed ID: 26725037
[TBL] [Abstract][Full Text] [Related]
3. [Pathogenesis and conservative therapy of uterine leiomyoma].
Mori T; Fujii S; Konishi I
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jul; 38(7):1144-9. PubMed ID: 3091738
[No Abstract] [Full Text] [Related]
4. Aromatase and leiomyoma of the uterus.
Shozu M; Murakami K; Inoue M
Semin Reprod Med; 2004 Feb; 22(1):51-60. PubMed ID: 15083381
[TBL] [Abstract][Full Text] [Related]
5. Treatment strategies for uterine leiomyoma: the role of hormonal modulation.
Cook JD; Walker CL
Semin Reprod Med; 2004 May; 22(2):105-11. PubMed ID: 15164305
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of the effect of raloxifene and gosereline on uterine leiomyoma volume changes and estrogen receptor, progesterone receptor, bcl-2 and p53 expression immunohistochemically in premenopausal women.
Baytur YB; Ozbilgin K; Cilaker S; Lacin S; Kurtul O; Oruc S; Koyuncu FM
Eur J Obstet Gynecol Reprod Biol; 2007 Nov; 135(1):94-103. PubMed ID: 16973256
[TBL] [Abstract][Full Text] [Related]
7. Estrogen biosynthesis in leiomyoma and myometrium of the uterus.
Yamamoto T; Takamori K; Okada H
Horm Metab Res; 1984 Dec; 16(12):678-9. PubMed ID: 6526370
[No Abstract] [Full Text] [Related]
8. Estrogen/antiestrogen responsiveness in an in vivo/in vitro model for myometrial tumorigenesis.
Howe SR; Everitt JI; Gottardis MM; Walker C
Ann N Y Acad Sci; 1995 Jun; 761():373-5. PubMed ID: 7625739
[No Abstract] [Full Text] [Related]
9. [Uterine fibromas and the hormonal pattern: the therapeutic considerations].
De Leo V; Morgante G
Minerva Ginecol; 1996 Dec; 48(12):533-8. PubMed ID: 9026748
[TBL] [Abstract][Full Text] [Related]
10. [Pathogenesis and histogenesis of uterine leiomyoma and their correlation with the endocrine functions].
Fujii S
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Aug; 35(8):1166-74. PubMed ID: 6578276
[No Abstract] [Full Text] [Related]
11. Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas.
Palomba S; Orio F; Russo T; Falbo A; Cascella T; Doldo P; Nappi C; Lombardi G; Mastrantonio P; Zullo F
Hum Reprod; 2004 Jun; 19(6):1308-14. PubMed ID: 15117890
[TBL] [Abstract][Full Text] [Related]
12. Does raloxifene inhibit the growth of uterine fibroids?
Palomba S; Zullo F; Orio F; Lombardi G
Fertil Steril; 2004 Jun; 81(6):1719-20; author reply 1720-1. PubMed ID: 15193512
[No Abstract] [Full Text] [Related]
13. A selective estrogen receptor modulator designed for the treatment of uterine leiomyoma with unique tissue specificity for uterus and ovaries in rats.
Hummel CW; Geiser AG; Bryant HU; Cohen IR; Dally RD; Fong KC; Frank SA; Hinklin R; Jones SA; Lewis G; McCann DJ; Rudmann DG; Shepherd TA; Tian H; Wallace OB; Wang M; Wang Y; Dodge JA
J Med Chem; 2005 Nov; 48(22):6772-5. PubMed ID: 16250633
[TBL] [Abstract][Full Text] [Related]
14. Extracellular matrix integrity: a possible mechanism for differential clinical effects among selective estrogen receptor modulators and estrogens?
Cox DA; Helvering LM
Mol Cell Endocrinol; 2006 Mar; 247(1-2):53-9. PubMed ID: 16426741
[TBL] [Abstract][Full Text] [Related]
15. Preclinical evidence for therapeutic efficacy of selective estrogen receptor modulators for uterine leiomyoma.
Walker CL; Burroughs KD; Davis B; Sowell K; Everitt JI; Fuchs-Young R
J Soc Gynecol Investig; 2000; 7(4):249-56. PubMed ID: 10964025
[TBL] [Abstract][Full Text] [Related]
16. [Estrogen production in women with uterine myoma].
Grigorov S
Akush Ginekol (Sofiia); 1971; 10(1):42-6. PubMed ID: 5137562
[No Abstract] [Full Text] [Related]
17. [Drug treatments for uterine fibroma: rationale].
Fernandez H; Azoulay C; Rostoker G;
J Gynecol Obstet Biol Reprod (Paris); 2005 Jun; 34(4):360-405. PubMed ID: 16136663
[No Abstract] [Full Text] [Related]
18. [Possibilities to use the aromatase inhibitors for the treatment of the uterine fibroids].
PersÃn J
Ceska Gynekol; 2006 Mar; 71(2):146-9. PubMed ID: 16649417
[TBL] [Abstract][Full Text] [Related]
19. [The role of hormones in the genesis of fibromyoma of the uterus].
Hakimova SM
Zentralbl Gynakol; 1968 Nov; 90(47):1588-603. PubMed ID: 5709575
[No Abstract] [Full Text] [Related]
20. [Treatment guideline for breast cancer and SERM-treatment].
Iwase H; Yamamoto Y; Kawasoe T
Nihon Rinsho; 2007 Nov; 65 Suppl 9():636-40. PubMed ID: 18159717
[No Abstract] [Full Text] [Related]
[Next] [New Search]
